Sunday, June 12, 2011

FDA Approves Dexamethasone Elixir and Orsythia

The FDA has approved Qualitest Pharmaceuticals’ dexamethasone elixir 0.5 mg/5 mL and Orsythia tablets (levonorgestrel/ethinyl estradiol tablets 0.1 mg/0.02 mg). Dexamethasone is used to treat a variety of conditions including endocrine disorders, rheumatic disorders, and collagen disease. Orsythia is indicated for the prevention of pregnancy in women who choose oral contraceptives as a method of contraception.

0 comments:

Post a Comment